The need for continuing chemotherapy for leukemic cell lysis pneumopathy in patients with acute Myelomonocytic/Monocytic Leukemia

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Although fatal pulmonary complications frequently occur during the course of acute leukemia, a minor proportion of the complications are due to leukemia itself. Infections, drug reactions and concomitant medical conditions are the major causes of respiratory distress in leukemic patients. We treated four patients with acute myeloid leukemia complicated by leukemic cell lysis pneumopathy (LCLP). All of the patients had leukemia of monocytoid origin and their respiratory function deteriorated soon after chemotherapy initiation. Although two of the patients required mechanical ventilation, all four improved after continued chemotherapy. Our experience indicates that, in cases of LCLP, chemotherapy should be continued with maximal respiratory support. © 2013 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Kato, A., Ono, Y., Nagahata, Y., Yamauchi, N., Tabata, S., Yonetani, N., … Ishikawa, T. (2013). The need for continuing chemotherapy for leukemic cell lysis pneumopathy in patients with acute Myelomonocytic/Monocytic Leukemia. Internal Medicine, 52(11), 1217–1221. https://doi.org/10.2169/internalmedicine.52.9117

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free